Log in
Log in
E-mail
Password

Show password
Remember
Forgot password ?
Become a member for free
Sign up
Become a member for free
Sign up
New member
Sign up for FREE
New customer
Discover our services
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Sotera Health Company
  6. Financials
    SHC   US83601L1026

SOTERA HEALTH COMPANY

(SHC)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Valuation
Fiscal Period: December 2020 2021 2022 2023 2024
Capitalization1 7 8026 6635 439--
Enterprise Value (EV)1 9 5608 3416 8696 7166 501
P/E ratio -172x57,4x30,9x22,9x19,6x
Yield -----
Capitalization / Revenue 9,54x7,15x5,33x4,90x4,50x
EV / Revenue 11,7x8,95x6,73x6,05x5,38x
EV / EBITDA 22,8x17,3x13,2x11,4x9,96x
Price to Book 14,4x11,4x6,09x5,04x4,11x
Nbr of stocks (in thousands) 284 321282 917282 817--
Reference price (USD) 27,423,619,219,219,2
Announcement Date 03/09/202103/01/2022---
1 USD in Million
Estimates
Income Statement Evolution (Annual data)
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net sales1 7788189311 0201 1101 207
EBITDA1 -420481522587653
Operating profit (EBIT)1 -357417451518571
Operating Margin -43,6%44,8%44,2%46,7%47,3%
Pre-Tax Profit (EBT) --38,9176---
Net income1 -20,9-38,6117174236278
Net margin -2,68%-4,72%12,5%17,1%21,2%23,0%
EPS2 --0,160,410,620,840,98
Dividend per Share2 ------
Announcement Date 09/02/202003/09/202103/01/2022---
1 USD in Million
2 USD
Estimates
Income Statement Evolution (Quarterly data)
Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4
Net sales1 226241237256256271
EBITDA1 117125115131132142
Operating profit (EBIT)1 10010899,5114115125
Operating Margin 44,3%44,8%42,0%44,4%44,7%46,0%
Pre-Tax Profit (EBT) ------
Net income1 27,436,030,642,544,751,6
Net margin 12,1%14,9%12,9%16,6%17,4%19,1%
EPS2 0,100,130,110,160,170,19
Dividend per Share ------
Announcement Date 11/10/202103/01/202205/05/2022---
1 USD in Million
2 USD
Previous periodNext period
Estimates
Balance Sheet Analysis
Fiscal Period: December 2019 2020 2021 2022 2023 2024
Net Debt1 -1 7581 6791 4301 2771 063
Net Cash position1 ------
Leverage (Debt / EBITDA) -4,19x3,49x2,74x2,17x1,63x
Free Cash Flow1 -67,1179229322416
ROE (Net Profit / Equities) --47,3%38,2%34,7%30,8%
Shareholders' equity1 --247456678904
ROA (Net Profit / Asset) -3,71%8,86%10,5%11,8%11,6%
Assets1 --1 0411 3201 6631 9922 393
Book Value Per Share2 -1,902,073,163,824,68
Cash Flow per Share -0,510,37---
Capex1 -53,5102154121104
Capex / Sales -6,54%11,0%15,1%10,9%8,61%
Announcement Date 09/02/202003/09/202103/01/2022---
1 USD in Million
2 USD
Estimates
Key data
Capitalization (USD) 5 438 575 409
Net sales (USD) 931 478 000
Number of employees 3 000
Sales / Employee (USD) 310 493
Free-Float 96,0%
Free-Float capitalization (USD) 5 223 121 594
Avg. Exchange 20 sessions (USD) 9 862 497
Average Daily Capital Traded 0,18%
EPS & Dividend
Year-on-year evolution of the PER
Change in Enterprise Value/EBITDA